USPTO serial 86932533
INGESTENGINE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- THOMPSON, HEATHER
- Law office
- TMEG LAW OFFICE 109 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with INGESTENGINE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Software for aggregating, managing and visualizing data related to pharmaceutical clinical trials, or obtained while conducting pharmaceutical clinical trials; Computer software for application and database integration; Computer software for controlling and managing patient medical information; Computer software for aggregating, managing and visualizing data related to pharmaceutical clinical trials, or obtained while conducting pharmaceutical clinical trials and instructional user guides sold as a unit; Computer software platforms for aggregating, managing and visualizing data related to pharmaceutical clinical trials, or obtained while conducting pharmaceutical clinical trials; Computer application software for aggregating, managing and visualizing data related to pharmaceutical clinical trials, or obtained while conducting pharmaceutical clinical trials, namely, software for aggregating, managing and visualizing data related to pharmaceutical clinical trials, or obtained while conducting pharmaceutical clinical trials; Computer hardware and software, for use with medical patient monitoring equipment, for receiving, processing, transmitting and displaying data; Database management software for aggregating, managing and visualizing data related to pharmaceutical clinical trials, or obtained while conducting pharmaceutical clinical trials; Downloadable cloud-based software for aggregating, managing and visualizing data related to pharmaceutical clinical trials, or obtained while conducting pharmaceutical clinical trials; Downloadable cloud-computing software for aggregating, managing and visualizing data related to pharmaceutical clinical trials, or obtained while conducting pharmaceutical clinical trials; Downloadable middleware for software application integration; Medical software for aggregating, managing and visualizing data related to pharmaceutical clinical trials, or obtained while conducting pharmaceutical clinical trials | ACTIVE | Mar 31, 2015 |
| 038 | Internet services, namely, providing multiple-user access to information on the internet concerning the development and generation of computer software for use in businesses as well as the functions and application of such business software | ACTIVE | Mar 31, 2015 |
| 042 | Software as a service (SAAS) services featuring software for aggregating, managing and visualizing data related to pharmaceutical clinical trials, or obtained while conducting pharmaceutical clinical trials; Software as a service (SAAS) services featuring software for aggregating, managing and visualizing data related to pharmaceutical clinical trials, or obtained while conducting pharmaceutical clinical trials; Software as a service (SAAS) services, namely, hosting software for use by others for use aggregating, managing and visualizing data related to pharmaceutical clinical trials, or obtained while conducting pharmaceutical clinical trials; Software authoring; Software design and development; Application service provider (ASP) featuring software for use aggregating, managing and visualizing data related to pharmaceutical clinical trials, or obtained while conducting pharmaceutical clinical trials; Application service provider featuring application programming interface (API) software for aggregating, managing and visualizing data related to pharmaceutical clinical trials, or obtained while conducting pharmaceutical clinical trials; Cloud computing featuring software for use aggregating, managing and visualizing data related to pharmaceutical clinical trials, or obtained while conducting pharmaceutical clinical trials; Computer software design; Computer software development; Computer software development and computer programming development for others; Computer programming and software design; Computer services, namely, acting as an application service provider in the field of information management to host computer application software for the purpose of aggregating, managing and visualizing data related to pharmaceutical clinical trials, or obtained while conducting pharmaceutical clinical trials; Computer services, namely, acting as an application service provider in the field of knowledge management to host computer application software for the purpose of aggregating, managing and visualizing data related to pharmaceutical clinical trials, or obtained while conducting pharmaceutical clinical trials; Consulting services in the field of providing online, non-downloadable software and applications; Data automation and collection service using proprietary software to evaluate, analyze and collect service data; Design and development of computer software for aggregating, managing and visualizing data related to pharmaceutical clinical trials, or obtained while conducting pharmaceutical clinical trials; Design and development of on-line computer software systems; Developing computer software; Development, updating and maintenance of software and database systems; Platform as a service (PAAS) featuring computer software platforms for aggregating, managing and visualizing data related to pharmaceutical clinical trials, or obtained while conducting pharmaceutical clinical trials; Providing a website featuring on-line non-downloadable software that enables users to aggregate, manage and visualize data related to pharmaceutical clinical trials, or obtained while conducting pharmaceutical clinical trials; Providing an Internet website portal in the fields of technology and software development; Providing information in the fields of technology and software development via an on-line website; Providing temporary use of online non-downloadable middleware for providing an interface between web browser and legacy systems; Updating and rental of software for data processing | ACTIVE | Mar 31, 2015 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 17, 2017 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jan 16, 2017 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jun 27, 2016 | UNDC | UNDELIVERABLE MAIL - COURTESY COPY MAILED | — |
| Jun 20, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 20, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 20, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 20, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 15, 2016 | MPMK | NOTICE OF PSEUDO MARK E-MAILED | — |
| Mar 14, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 11, 2016 | NWAP | NEW APPLICATION ENTERED | — |